Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
The killer immunoglobulin-like receptor KIR3DL1 in combination with HLA-Bw4 is protective against multiple sclerosis in African Americans.
MRI to Discriminate Pediatric MS from ADEM.
The common marmoset as an indispensable animal model for immunotherapy development in multiple sclerosis.
[Capabilities of positron emission tomography to study mecha-nisms of multiple sclerosis: own data and literature].
New clinical insights into combined central and peripheral demyelination (CCPD).
Genetic loci for Epstein-Barr virus nuclear antigen-1 are associated with risk of multiple sclerosis.
Bone marrow-derived macrophages and the CNS: An update on the use of experimental chimeric mouse models and bone marrow transplantation in neurological disorders.
[Differntial diagnosis of neuromyelitis optica].
Chances and challenges of retinoid X receptor gamma targeting for regenerative multiple sclerosis treatment.
Optimization of Intravenous Immunoglobulin in Chronic Inflammatory Demyelinating Polyneuropathy Evaluated by Grip Strength Measurement.
Paradoxical Effect of Cortistatin Treatment and Its Deficiency on Experimental Autoimmune Encephalomyelitis.
Multiple Sclerosis treatment and infectious issues: Update 2013.
[Cavitary lesions in multiple sclerosis: Multicenter study on twenty patients.]
Assessment of bone densitometry in Iranian patients with multiple sclerosis: A case-control study.
Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
Social network diversity and white matter microstructural integrity in humans.
Relapse of neuromyelitis optica during pregnancy-Treatment options and literature review.
Overcoming Drug Development Bottlenecks With Repurposing: Old drugs learn new tricks.
Changes of statistical structural fluctuations unveils an early compacted degraded stage of PNS myelin.
Interferon beta use and disability prevention in relapsing-remitting multiple sclerosis.
Multiple sclerosis: autoimmunity and viruses.
Symptomatic brain involvement as the initial manifestation of neuromyelitis optica.
Impairment of JCV-specific T-cell response by corticotherapy: Effect on PML-IRIS management?
A tissue-relaxation-dependent neighboring method for robust mapping of the myelin water fraction.
The economic impact of multiple sclerosis in Australia in 2010.
Pages
« first
‹ previous
…
611
612
613
614
615
616
617
618
619
…
next ›
last »